Sudden Cardiac Death in Patients With Stable Coronary Artery Disease and Preserved Left Ventricular Systolic Function

American Journal of Cardiology

Volumn 101, Issue 4, 2008, Pages 457-461

  Hsia, Judith ^a   Jablonski, Kathleen A ^b   Rice, Madeline Murguia ^b   Sabatine, Marc S ^c   Zabalgoitia, Miguel ^d   Maggioni, Aldo ^e   Cuddy, Thomas E ^f   Domanski, Michael J ^g   Geller, Nancy L ^g   Flaker, Greg ^h   Solomon, Scott ^c   Omland, Torbjørn ⁱ   Rouleau, Jean L ^j  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Mays Cancer Center at UT Health San Antonio   (United States)

^e AMNCO Foundation   (Italy)

^f UNIVERSITY OF MANITOBA   (Canada)

^g NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^h University of Missouri   (United States)

ⁱ AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^j UNIVERSITÉ DE MONTRÉAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIURETIC AGENT; PLACEBO; POTASSIUM SPARING DIURETIC AGENT; TRANDOLAPRIL;

ADULT; AGED; ALGORITHM; ANGINA PECTORIS; ARTICLE; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; GROUPS BY AGE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SCORING SYSTEM; SECONDARY PREVENTION; SEX DIFFERENCE; SUDDEN DEATH; SYSTOLE;

AGE FACTORS; ALGORITHMS; ANGINA PECTORIS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOTONIC AGENTS; CONTINENTAL POPULATION GROUPS; CORONARY ARTERY DISEASE; DEATH, SUDDEN, CARDIAC; DIGITALIS GLYCOSIDES; DIURETICS; FEMALE; HUMANS; INDOLES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SEX FACTORS; STROKE VOLUME; SYSTOLE; VENTRICULAR FUNCTION, LEFT;

EID: 38849089301     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.09.107     Document Type: Article

References (21)

1. Parkash R., Stevenson W.G., Epstein L.M., and Maisel W.H. Predicting early mortality after implantable defibrillator implantation: a clinical risk score for optimal patient selection. Am Heart J 151 (2006) 397-403
2. Solomon S.D., Zelenkofske S., McMurray J.J., Finn P.V., Velazquez E., Ertl G., Harsanyi A., Rouleau J.L., Maggioni A., Kober L., et al., Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 352 (2005) 2581-2588
3. Mäkikallio T.H., Barthel P., Schneider R., Bauer A., Tapanainen J.M., Tulppo M.P., Perkiömäki J.S., Schmidt G., and Huikuri H.V. Frequency of sudden cardiac death among acute myocardial infarction survival with optimized medial and revascularization therapy. Am J Cardiol 97 (2006) 480-484
4. Klingenheben T. Arrhythmia risk prediction in patients with preserved left ventricular function: the final frontier?. J Am Coll Cardiol 48 (2006) 2275-2276
5. Ikeda T., Yoshino H., Sugi K., Tanno K., Shimizu H., Watanbe J., Kasamaki Y., Yoshida A., and Kato T. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction. J Am Coll Cardiol 48 (2006) 2268-2274
6. Pfeffer M.A., Domanski M., Verter J., Dunlap M., Flaker G.C., Gersh B., Hsia J., Goldberg A.D., Limacher M.C., Maggioni A.P., et al., PEACE Investigators. The continuation of the Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) trial. Am Heart J 142 (2001) 375-377
7. Braunwald E., Domanski M.J., Fowler S.E., Geller N.L., Gersh B.J., Hsia J., Pfeffer M.A., Rice M.M., Rosenberg Y.D., Rouleau J.L., and PEACE Trial Investigators. Angiotensin converting enzyme inhibition in stable coronary artery disease. N Engl J Med 351 (2004) 2058-2068
8. Belsley D.A., Kuh E., and Welsch R.E. Regression Diagnostics (1980), John Wiley & Sons, New York 112-113
9. Hosmer D., and Lemeshow S. Applied Survival Analysis (1999), John Wiley & Sons, New York 205-216
10. Assmann G., Cullen P., and Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-7 year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 105 (2002) 310-315
11. Pencina M.J., and D'Agostino R.B. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 23 (2004) 2109-2123
12. Rassi Jr. A., Rass A., Little W.C., Xavier S.S., Rassi W.G., Rassi A.G., Rassi G.G., Hasslocher-Moreno A., Sousa A.S., and Scanavacca M.I. Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med 244 (2006) 799-808
13. Domanski M.J., Exner D.V., Borkowf C.B., Geller N.L., Rosenberg Y., and Pfeffer M.A. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 33 (1999) 598-604
14. Teo K.K., Mitchell L.B., Pogue J., Bosch J., Dagenais G., Yusuf S., and HOPE Investigators. Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction. Circulation 110 (2004) 1413-1417
15. Capone R.J., Pawitan Y., el-Sherif N., Geraci T.S., Hanshaw K., Morganroth J., Schlant R.C., and Waldo A.L. Events in the cardiac arrhythmia suppression trial: baseline predictors of mortality in placebo-treated patients. J Am Coll Cardiol 18 (1991) 1434-1438
16. Amsallem E., Kasparian C., Haddour G., Boissel J.P., and Nony P. Phosphodiesterase III inhibitors for heart failure. Cochrane Database Syst Rev 1 (2005) CD002230
17. Pederson O.D., Abildstrøm S.Z., Ottesen M.M., Rask-Madsen C., Bagger H., Køber L., Torp-Pedersen C., and TRACE Study investigators. Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction. Eur Heart J 27 (2006) 290-295
18. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288 (2002) 2981-2997
19. Burke A.P., Tracy R.P., Kolodgie F., Malcom G.T., Zieske A., Kutys R., Pestaner J., Smialek J., and Virmani R. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 105 (2002) 2019-2023
20. Huikuri H.V., Tapanainen J.M., Lindgren K., Raatikainen P., Mäkikallio T.M., Airaksinen K.E.J., and Myerburg R.J. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol 42 (2003) 652-658
21. Bunch T.J., Hohnloser S.H., and Gersh B.J. Mechanisms of sudden cardiac death in myocardial infarction survivors. Circulation 115 (2007) 2451-2457